Inclusion Criteria:  Capable of providing written informed consent / have a legal representative to provide written informed consent. *  Having been randomized to one of the four treatment arms (aripiprazole oral, aripiprazole depot, paliperidone oral, paliperidone depot) in the 2014-002765-30 EULAST-I clinical trial or having participated in the EULAST-I naturalistic cohort study.  Unless prohibited by local law (e.g. due to incarceration).  Exclusion Criteria: No exclusion criteria are applicable in this study.